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ABSTRACT 
Introduction: Unrecognized renal insufficiency, deﬁned as an estimated 
glomerular ﬁltration rate <60 mL/min/1.73 m2 in the presence of normal serum 
creatinine levels, is a common comorbid condition among patients with various 
cardiovascular conditions. The current study was aimed to evaluate the 
prevalence and clinical signiﬁcance of unrecognized renal dysfunction in 
patients admitted with acute stroke. 
Methods: This cross sectional study consisted of patients with acute stroke 
admitted in medical ward at Stanley medical college. Estimated glomerular 
ﬁltration is estimated using MDRD and CKD – EPI formula. Study group is 
divided into three groups (normal renal function, unrecognized and recognized 
renal dysfunction) as per eGFR. The two primary outcomes such as severe 
disability at hospital discharge and in-hospital mortality are compared in each 
group. 
Results: Of the 100 patients with stroke included in the study, 62% had normal 
renal function, 31% had recognized renal insufﬁciency, and 7% had 
unrecognized renal insufﬁciency. Mortality rates are higher in patients with 
recognized and unrecognized renal insufﬁciency compared with patients with 
normal renal function (29%, %, and 28.5% and 9.6%) respectively, P < 
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0.04053). Similarly, severe disability rates at discharge are also higher in 
patients with recognized and unrecognized renal insufﬁciency compared with 
patients with normal renal function (72.27%, 80 %, and 32.14%) respectively. 
Conclusion: Unrecognized renal insufﬁciency is common among patients with 
acute stroke and is associated with adverse short-term outcomes. 
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INTRODUCTION 
Stroke or cerebrovascular accident is defined as abrupt onset of neurological 
disorder such as sudden decrease or loss of consciousness, voluntary movement 
or sensation caused by occlusion of blood vessel or rupture. Renal insufﬁciency 
is a strong predictor of adverse out-comes in patients with various 
cardiovascular disorders including stroke. Despite its clinical signiﬁcance, renal 
insufﬁciency is frequently unrecognized. Although the renal function has been 
assessed routinely using serum creatinine, it is an unreliable proxy inﬂuenced by 
various factors including age, sex, race, and lean body weight. Patients with 
serum creatinine levels slightly more than the upper limit or even within the 
normal range may have renal dysfunction, which may often be clinically 
signiﬁcant. The term unrecognized renal insufficiency is deﬁned as an estimated 
glomerular ﬁltration rate <60 mL/min/1.73 m2 in the presence of serum 
creatinine ≤ 1.2 mg/ dl. The group of patients having unrecognized renal 
insufﬁciency signify a high-risk group with greater mortality rate compared to 
patients with normal renal function. Hence, renal function in stroke patients 
should be assessed by glomerular filtration rate instead of serum creatinine. 
 
  
4 
 
Review of Literature 
2.1 Brain Anatomy 
The most metabolically active organ in our body is brain. Although it represents 
merely 2% of the body mass, it serves numerous vital functions and requires 15 
to 20% of cardiac output at rest. Cerebral hemispheres form the greater part of 
the brain and are supplied by 3 paired major arteries named anterior, middle and 
posterior cerebral arteries. Anterior circulation is carried by anterior and middle 
cerebral artery. Middle cerebral artery is the dominant arterial source to the 
brain. It supplies the lateral portions of frontal, parietal, temporal lobes, anterior 
portion of temporal lobe, Globus pallidus, Putamen and Internal capsule. 
Posterior circulation is carried by Posterior cerebral artery which supplies 
thalamus, brainstem, posterior and medial parts of temporal and occipital lobes.  
2.2 Cerebrovascular Accident 
Stroke or cerebrovascular accident is defined as abrupt onset of neurological 
disorder such as sudden decrease or loss of consciousness,  voluntary movement  
or sensation caused by breach or occlusion  (as by a clot) of a blood vessel of the 
brain—also known as brain attack, apoplexy, cerebral accident or 
cerebrovascular accident. Stroke is the third major cause of morbidity and 
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mortality in india [40] after myocardial infarction. It is one of the important 
causes of adult disability. Direct causes are  
1) Cerebral thrombosis 
2) Cerebral aneurysm rupture 
3) Severe rise in blood pressure causing hemorrhage or ischemia [25] and  
4) Cerebral embolism 
Stroke may be hemorrhagic or ischemic. Almost 85% of all strokes are 
ischemic. But hemorrhagic stroke is responsible for 30% of all stroke deaths. 
Ischemic stroke may turn into hemorrhagic transformation after reperfusion 
especially in patients treated with thrombolysis or endovascular intervention [4, 
13]. 
Latest studies found that reduced GFR is associated with both hemorrhagic as 
well as ischemic stroke. Hence, renal dysfunction is an independent risk factor 
(table 1) for mortality outcome of stroke as well as new cardiovascular events 
[3, 9, and 2]. 
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Table 1 Risk factors for stroke  
 All age groups 
 
Younger age 
Elderly, age >55 years 
 
Hypertension, Diabetes, CKD 
 
Smoking, Alochol intake 
 
Arrhythmias 
 
Dilated cardiomyopathy 
 
Family H/O stroke 
 
Vasculitis 
 
Use of cocaine or amphetamines 
 
Oral contraceptives intake 
 
Protein C, S deficiencies 
 
Antithrombin III deficiency 
 
Antiphospholipid syndrome 
 
Factor V Leiden mutation 
 
Sickle cell anemia 
 
Hyperhomocysteinaemia 
 
Arterial dissection 
 
Thrombotic thrombocytopenic 
purpura 
 
Syphilis, HIV 
 
 
 
2.2.1 Cicinnati Prehospital stroke scale 
In prehospital phase this scale is used to detect stroke early. It can be 
remembered by acronym “FAST” – Facial asymmetry, Arm drift, Speech 
abnormality and Time of onset. Common stroke signs and symptoms are abrupt 
onset of limb weakness in the form of monoparesis, hemiparesis or 
quadriparesis,  hemisensory deficits, visual defects, sudden decrease in the level 
of consciousness, diplopia, Dysarthria, Facial droop, ataxia, vertigo and 
nystagmus [6]. 
7 
 
Table 2 Differences between Hemorrhagic, Thrombotic and Embolic strokes 
Feature Hemorrhagic Thrombotic Embolic 
Time of onset During activity In sleep Any time 
Progression Over minutes Over hours Within 
seconds 
TIAs Absent Present Present 
Vomiting Recurrent - - 
Headache Prominent - - 
Early resolution 
within minutes 
or days 
Unusual Variable Possible 
Meningeal 
irritation 
+/- - - 
Carotid bruit - Highly supportive Possible 
Valvular heart 
disease & 
Atrial 
fibrillation 
- Unusual Highly 
supportive 
CT brain Hemorrhage Pale infarct Pale infarct, 
Hemorrhagic 
infarct in 
some cases 
 
2.2.2 Ischemic stroke 
 It is characterized by sudden cessation of blood circulation to a particular area 
of brain, leading to loss of neurological function corresponding to that area. It is 
caused by embolic or thrombotic occlusion of a cerebral artery. An ischaemic 
stroke classically presents with rapid onset neurological deficit, which is 
determined by the area of brain supplied by the involved artery. The signs and 
symptoms usually evolve over hours, and may deteriorate or recover, depending 
on the destiny of the ischaemic penumbra. Types of ischemic stroke are transient 
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ischemic attacks, completed stroke, lacunar infarcts and watershed infarcts. 
Multifocal small infarcts or ischemia may produce slowly progressive 
neurological disorders – multi infarct dementia and subcortical arteriosclerotic 
encephalopathy (Binswanger’s disease). The brain has no glucose storage and 
also more sensitive to hypoxia. Therefore, any critical reduction of cerebral 
blood flow for more than 2 -3 minutes will rapidly instigate a cellular level 
ischemic cascade ultimately leading to cell death [10,39]. 
Table 3 Fate of brain tissue and cerebral blood flow 
Events Cerebral blood flow (%) 
Normal >50 
Oligaemia-reduced cerebral blood 
flow but retained neuronal activity 
 
21-50 
Ischemic penumbra-Loss of 
electrical activity but viable tissue 
 
11-20 
Irreversible neuronal death 6-10 
 
2.2.3 Transient ischemic attacks 
It is a transitory episode of neurological deficit, not lasting more than 24 hours 
due to ischemia of a particular region of the brain or retinal ischemia with 
normal neuroimaging without any evidence of acute infarction. So it is not 
possible to diagnose TIA without diagnostic imaging [8]. TIA occurs due to a 
platelet thrombus getting detached from an atherosclerotic plaque to produce 
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short lasting blockade at a distal branch. Then embolus gets broken down and 
disappear resulting in restoration of perfusion with reversal of neurological 
dysfunction. 
 Factors associated with high risk of recurrence of stroke within three months  
 1) Age more than 60 years  
 2) Symptom duration more than 10 minutes 
 3) Weakness 
 4) Speech impairment 
 5) Diabetes mellitus 
Causes of TIAs: 
1) Large artery atherosclerosis – Carotid stenosis, Vertebrobasilar disease, 
Aortic atherosclerosis. 
2) Cardio aortic embolism – Atrial fibrillation, Valvular heart disease, Left 
ventricle thrombus. 
3) Intracranial small vessel diseases from long standing hypertension, 
intracranial atherosclerosis. 
4) Others – Hypercoagulable states, Arterial dissection  
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2.2.4 Stroke in evolution 
In few patients focal neurological deficits may worsen stepwise over few hours 
or days. It occurs due to gradual occlusion of major blood vessel by a thrombus. 
It may also occur in a rapidly growing tumor and subdural hematoma [7]. 
2.2.5 Lacunar infarction 
They are small deep infarcts usually less than 15mm. Occurs secondary to 
diseases of small perforating branches of brain. Lacunar infarction is usually 
associated with hypertension, Diabetes, Smoking or micro embolism from heart 
or carotid arteries. Causes of lacunar stroke are lipohyalinosis, micro atheroma, 
fibrinoid necrosis due to hypertension or vasculitis, hyaline arteriosclerosis, 
amyloid angiopathy and microemboli. There are five classic syndromes in 
lacunar stroke are as follows; a) pure motor stroke, b) pure sensory stroke, c) 
mixed sensorimotor stroke, d) ataxic hemiparesis and e) dysarthria clumsy hand 
syndrome. 
2.2.6 Watershed infarct 
Ischemia that is localized to the vulnerable border zones between the tissues 
supplied by anterior, middle and posterior cerebral arteries is called watershed 
infarct. It contributes about 10% of all ischemic strokes. They are particularly 
susceptible to infarction from profound hypo perfusion. They are localized to 
two primary regions of brain, cortical watersheds and internal watersheds. 
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2.2.7 Ischemic Penumbra 
The area surrounding an ischemic area of the brain is named as Penumbra. 
Penumbra is defined as ischemic tissue potentially destined for infarction but 
still it is reversible if treated properly and hence, the target for any acute 
therapies. Reducing blood pressure in acute ischemic stroke can damage 
penumbra irreversibly. But there is no accurate blood pressure target has been 
defined yet. AHA guidelines recommend not reducing BP unless it exceeds 
220/120 mmHg [11]. 
 2.2.8 Types of Hemorrhagic strokes 
There are four types of hemorrhagic strokes, including 1) Primary intracerebral 
hemorrhage, 2) Primary intraventricular hemorrhage, 3) Subarachnoid 
hemorrhage and 4) Intracerebral hemorrhage. The common sites of hypertensive 
bleeding are Putamen, Thalamus, Frontal, Parietal lobes, Pons and Cerebellum. 
2.2.9 Subarachnoid hemorrhage 
Subarachnoid hemorrhage accounts for 10% of all strokes. Common causes are 
rupture of aneurysm of circle of willis, AV malformations, Trauma, extension of 
intracerebral bleed, Mycotic aneurysm, Bleeding diathesis and anticoagulant 
treatment. Characteristic feature is abrupt onset headache with or without 
vomiting. Headache may be associated with neck stiffness, seizures, loss of 
consciousness or focal neurological deficits. Rebleeding, hydrocephalus, 
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hyponatremia, seizures, vasospasm are the common complications of SAH. A 
study found that even trivial changes in creatinine clearance are associated with 
considerable worst outcomes in patients with aneurysmal SAH. 
2.2.10 Cerebral venous sinus thrombosis 
Generally, the cerebral venous sinus thrombosis is the cause 1 -2% of strokes in 
young adults. Superior sagittal sinus is commonly involved. 
2. 2.11 Stroke syndromes 
A) Anterior cerebral artery syndrome 
 Contralateral weakness and sensory loss commonly occur in Lower Limbs. 
Aphasia, Urinary incontinence, Loss of social inhibition and may have memory 
deficits. 
B) Middle cerebral artery syndrome 
Contralateral weakness and sensory loss more commonly occur in face and 
upper extremities.  Homonymous hemianopia, spatial disorganization, 
Wernicke’s aphasia if dominant hemisphere is involved and unilateral neglect 
C) Vertebral basilar artery occlusion 
1. Headache, dizziness, ataxia 
2. Hemiplegia or tetraplegia 
3. Cranial nerve palsies 
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 4. Locked in syndrome 
  5. Loss of consciousness 
D) Posterior cerebral artery occlusion 
1. Contralateral sensory loss  
2.  Thalamic pain syndrome – intolerable burning pain and sensory 
perseveration 
3.  Memory deficits 
4. Homonymous hemianopia 
5. Visual agnosia  
6. Cortical blindness 
E) Differential Diagnosis of stroke 
1. Metabolic or Toxic encephalopathy 
2. Post ictal Todd’s palsy 
3. Hemiplegic migraine 
4. Hypertensive encephalopathy 
5. Conversion disorders 
6. Encephalitis, Brain abscess 
7. Head injury 
8. Structural intracranial lesions 
9. Relapsing multiple sclerosis 
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Table 4 Risk assessment for occurrence of stroke – ABCD2 score* 
Predictor Points 
Age > 60 years 1 
Blood pressure > 140/90 mmHg 1 
Clinical features (maximum 2) 
Unilateral weakness (2) 
Speech difficulty without weakness (1) 
2 
Duration (maximum 2) 
> 60 mins (2) 
10 to 59 mins (1) 
< 10 mins (0) 
2 
Diabetes 1 
Maximum total score 7 
         * High risk of early stoke if ABCD2 score more than 3 points. 
F) Investigations 
Complete blood count may reveal few rare causes for stroke such as 
polycythemia, leukemia, thrombocytopenia and thrombocytosis. Basic 
biochemistry investigations like blood sugar, Renal function test, Serum 
electrolytes to rule metabolic causes of stroke. They also provide evidence for 
concurrent illness – Diabetes, renal dysfunction and dyselectrolytemia. Serum 
creatinine helps to calculate EGFR which is more significant to find out renal 
dysfunction especially unrecognized renal dysfunction. ECG is must to find out 
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arrhythmias and coronary artery disease. In some patients hemorrhagic stroke 
may occur due to brain secondary from lung malignancy. Hence, chest x ray 
should be the part of the routine investigation. It also gives clues about the 
cardiac size [41]. 
 Young patients need some special investigations  such as 
 Anti-nuclear antibody screening 
 Serological test for syphilis 
 Anticardiolipin antibodies  
 Protein C, S 
 Antithrombin III 
CT brain:  Non-contrast CT brain remains the mainstay of imaging because it is 
the fast, relatively inexpensive and readily available investigation in the setting 
of an acute stroke. However, its main limitation is less sensitivity to find out 
ischemic stroke in the acute setting.  CT brain should be taken immediately to 
rule out hemorrhage, tumor and subdural hematoma. Large infarcts with edema 
can be visualized during the first few hours of stroke [41]. The key aims of CT 
brain in acute setting are 1) rule out intracranial haemorrhage, which would 
prevent thrombolysis 2) look for early features of infarction 3.exclude other 
intracranial lesions that may mimic a stroke, such as tumour.  
16 
 
 
Fig. 1 Acute infarct: images of CT brain 
Non contrast CT brain (fig 1) demonstrates acute massive infarct and sulcal 
effacement including the left anterior and middle cerebral artery territories. 
Occasionally, earliest sign of acute infarct visible as hyperdense fragment of a 
vessel, demonstrating direct visualisation of the intravascular embolus / 
thrombus [41, 42]. Though this could be detected in any vessel, it is most often 
witnessed in the middle cerebral artery known as hyperdense middle cerebral 
artery sign. Hyperdense MCA sign is seen within 60 to 90 minutes of the 
ischemic event. It is the 'golden hour' of thrombolysis to save the patient. This 
sign is approximately 100% sensitivity, however only 30% specificity. 
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Fig. 3 Acute Dense MCA sign images of CT brain 
 
 
 
Fig. 4 CT brain of acute parenchymal hemorrhage - Plain CT brain shows 
hyperdense lesion with mass effect in left frontal area. 
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Fig. 5 CT brain of subarachnoid hemorrhage: High density subarachnoid blood 
seen in basal cisterns, sylvian fissures and within the fourth ventricle. 
 
Diffusion weighted MRI of brain:  It is the most sensitive and specific for 
ischemic stroke [42]. 
CT or MR angiography: It is necessary if either intra- arterial fibrinolysis or 
mechanical thrombectomy [41] has been planned and also to rule out aneurysm. 
Carotid Doppler: 4 Vessel Carotid Doppler is a safe, more economic, not much 
time-consuming and establishing the extra cranial carotid artery causes of 
cerebrovascular accident [43]. 
2.2.12 Stroke Prevention 
Prevention plays a vital role in preventing mortality and morbidity associated 
with stroke. It has been assessed that 50% of stroke are preventable by life style 
modifications and controlling risk factors that are modifiable [14]. 
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A) Control of blood pressure and blood sugar: 
Hypertension is the most significant modifiable risk factor for stroke. It adds to 
50 to 60% of all strokes (atheroma of main vessels, friability of small cerebral 
vessels, atrial fibrillation, and left ventricular dysfunction). There is direct 
relationship between blood pressure and stroke incidence in both normotensive 
as well as hypertensive group. Fall of 5-6 mm Hg diastolic blood pressure has 
been associated with a 42% relative risk reduction of first stroke event [15]. 
Literatures demonstrate that diabetes is also a major risk factor for first ischemic 
stroke [16, 17]. Furthermore, the role of tight blood sugar control in reducing the 
risk of stroke event is still unclear [18]. Patients with diabetes have poor 
recovery, more severe disability score and greater mortality. Rate of recurrent 
stroke is more in patients having diabetes mellitus when compared to 
nondiabetic stroke patients [19, 20]. 
B) Cessation of smoking and alcohol intake 
Various types of strokes such as ischemic, hemorrhagic stroke and subarachnoid 
hemorrhage are strongly associated with smoking.  Kurth et al., 2003, reported 
the risk of hemorrhagic stroke in male as well as female smokers [21, 22]. These 
studies showed an increased risk of total hemorrhagic stroke, and SAH in 
females smoking ≥15 cigarettes per day and males smoking ≥20 cigarettes per 
day. Chronic alcohol consumption more than 60 g / day is associated with 
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increased risk of developing stroke through various mechanisms [25]. Alcohol 
induces hypertension, cardiac arrhythmias, enhanced platelet activation and 
aggregation [23] and cerebral vasospasm [24]. Ethanol itself is a direct 
neurotoxin.  
C) Regular exercise and weight control 
Exercise activity, irrespective of weight loss, gives several health benefits 
exclusively for overweight and obese individuals which in turn prevent many 
cardiovascular conditions. Weight loss is possible by both exercise and calorie 
restriction.  Combination of exercise and calorie restriction is superior because 
exercise improves insulin resistance [44]. 
D) Increasing public awareness about early warning signs of CVA 
Stroke is frequently preceded by warning symptoms such as headache, limb 
weakness, giddiness, face drooping, visual disturbance and difficulty in speech 
that usually lasts less than five minutes, and does not injure the brain. This 
typically occurs within seven days of major stroke [45].  Hence, patients who 
are at high risk of stroke should be educated for early warning signs of stroke. 
2.2.13 Management of CVA 
Successful care of acute stroke patients relies on “Stroke Chain of Survival”.  
1. Detection of onset of stroke signs and symptoms early  
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2. Dispatch through activation of emergency medical services and prompt           
response 
3.  Delivery of patient to a pre- notified hospital with appropriate prehospital 
care 
4. Immediate emergency department triage 
5. Data compilation including CT brain 
6. Decision regarding potential therapies  
7. Drug therapy 
8. Timely transfer to stroke unit 
A) General measures 
Treatment of comorbid conditions like reduction of fever, correct hypo or 
hypertension, correct hypo or hyperglycemia and management of myocardial 
ischemia and arrhythmias.  
BP control: Urgent reduction of BP is necessary only when the blood pressure is 
more than 220/120 mmHg or mean arterial pressure is more than 130mmHg [4]. 
And also if the patient has pulmonary edema, renal failure, acute myocardial 
infarction, etc. In patients undergoing thrombolytic therapy antihypertensives 
are needed if BP more than 185/110mmHg.   
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B) Anti edema measures   
Anti-edema measures is used in large infarct with significant edema. Commonly 
20% Mannitol 0.25mg/Kg has been used along with furosemide.  
C) Thrombolytic therapy 
Ischemic stroke therapies include fibrinolytic therapy, antiplatelet agents and 
mechanical thrombectomy. Intravenous recombinant tissue plasminogen 
activator is useful if initiated within 3-4 hours. Contraindications to 
thrombolysis are hemorrhagic CVA, bleeding diathesis, BP more than 185/110 
mmHg, major neurosurgery or head injury within 3 months, H/O intracranial 
hemorrhage or AV malformation or active internal bleeding. Intra-arterial 
thrombolysis via carotid artery can be given within 6 hours. If patients present 
with more than 6 hours thrombolysis is not useful. 
D) Anticogulants  
Anticoagulants are recommended only in mild ischemic events in the presence 
of stroke in evolution. 
1) Atrial fibrillation 
2)  Prosthetic valves 
Previous myocardial infarction with akinetic ventricles 
 Cerebral venous sinus thrombosis  
 
23 
 
E) Management of Subarachnoid hemorrhage 
Antihypertensives if systolic BP is more than 140mmHg. Beta blockers are the 
drug of choice if there are no contraindications. Nimodipine is useful as it 
reduces cerebral vasospasm .Nitrates should be avoided because they elevate 
intracranial pressure. Hyperventilation should be avoided because it may 
potentiate vasospasm and ischemia. Head end should be elevated at 30 degree to 
improve venous drainage. Endovascular clipping or coiling of aneurysm is 
indicated to prevent rebleeding [23]. 
F)  Management of hemorrhagic CVA 
If intracerebral hemorrhage volume less than 10 ml or patients present with 
minimal neurological deficits, consider non-surgical conservative management. 
Surgery is required if cerebellar hemorrhage more than 3 cm, intracerebral 
hemorrhage with structural vascular lesion and in young patients with lobar 
hemorrhage. Surgical approaches are craniotomy and clot evacuation under 
direct visual guidance, stereotactic aspiration with thrombolytic agents and 
endoscopic evacuation. 
2.2.14 Secondary complications in CVA 
 Stroke patients are susceptible to various complications such as deep vein 
thrombosis, bed sores, complex regional pain syndrome, decreased flexibility 
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and aspiration pneumonitis [46]. Aspiration pneumonitis is the most common 
cause of death in stroke. 
2.2.15 Recovery 
Most survivors of a stroke have residual disability. Rehabilitation in the initial 
six months period should focus to maximize patient’s physical activity and to be 
continued regularly. 
2.3 Renal System 
2.3.1 Anatomy of the Kidneys  
The two kidneys are retroperitoneal organ located in the posterior abdominal 
wall. Each kidney weighs about 150 grams. Renal vessels, lymphatics, nerve 
and ureter pass through the hilum present in medial side of each kidney. The 
kidney is enclosed in a thick fibrous capsule that protects inner delicate 
structures. The kidney is divided into outer cortex and the inner medulla. The 
inner medulla is divided into 8 to 10 renal pyramids. The renal pyramids 
originate at the junction between cortex and medulla and end in papilla, which 
project into the renal pelvis. Functional unit of the kidney is smallest micro 
anatomical structure named as nephron. Nephron is divided into proximal and 
distal convoluted tubule connected by loop of henle. Each segment of the 
nephron consists of functionally and structurally characteristic cells. [27] 
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2.3.2 Functions of the Kidneys 
The kidneys are the principal organs to excrete waste products that are produced 
by metabolism or digestion of ingested food. These products include creatinine 
from creatine phosphate in muscle, urea from amino acids metabolism, uric acid 
from nucleic acids, bilirubin from hemoglobin and heme containing enzymes, 
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and metabolites of many hormones. The kidneys also excrete most toxins, drugs 
and food additives. The most important function of kidneys is to maintain 
internal balance of, particularly water and electrolytes such as sodium, 
potassium, chloride, calcium, phosphorus and magnesium [33]. The kidneys also 
have got endocrine function. It synthesizes erythropoietin which is needed for 
red blood production and 1, 25-dihydroxycholecalciferol (calcitriol) necessary 
for bone formation. Most important homeostatic functions are 
1) Excretion of metabolic waste materials 
2) Secretion, metabolism, and excretion of hormones 
3) Water and electrolyte balance. 
4) Acid base balance 
5) Regulation of blood pressure 
6) Gluconeogenesis 
2.3.3. Renal Blood Supply 
The kidneys receive 1.2 to 1.3 liters of blood or about 25% of the resting cardiac 
output [47]. Glomerulus receives capillaries from afferent arterioles. 
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 Afferent arterioles are short straight branches of inter lobar arteries originating 
from renal artery a branch of abdominal aorta. Each afferent arteriole divides 
into multiple capillary branches. 20 to 50 such fenestrated capillary loops form 
glomerulus. Distal ends of the glomerular capillaries merge to form the efferent 
arteriole. Efferent arteriole forms peritubular capillaries that surround the renal 
tubule and emptying into renal vein.  
A) Renal Blood Flow determinants  
Renal blood flow is determined by the pressure difference between renal artery 
and renal vein divided by total renal vascular resistance. 
RBF =
𝑅𝑒𝑛𝑎𝑙 𝑎𝑟𝑡𝑒𝑟𝑦 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 − 𝑅𝑒𝑛𝑎𝑙 𝑣𝑒𝑖𝑛 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
𝑇𝑜𝑡𝑎𝑙 𝑟𝑒𝑛𝑎𝑙 𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒
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Renal arterial pressure is equal to systemic arterial pressure. Total renal vascular 
resistance is determined by summation of the resistances in the individual 
vessels including arteries, arterioles, capillaries and vein.  
Though fluctuations in arterial pressure have some influence on renal blood 
flow, the kidneys have effective tools to maintain renal blood flow and GFR at 
fairly constant rate over a range between 80 and 170 mmHg of arterial pressure. 
This process is known as autoregulation. Mechanism of autoregulation is 
completely intrinsic to the kidney [28]. 
Intrinsic mechanism 
The kidneys have intrinsic feedback mechanisms that usually keep the renal 
blood flow and glomerular filtration rate relatively constant, independent of 
systemic influences despite changes in arterial blood pressure. This is known as 
autoregulation [28]. The significance of autoregulation in tissues is to maintain 
the delivery of nutrients and oxygen at a normal level and to eliminate the waste 
products of metabolism, even when arterial pressure changes. Kidneys receive 
much higher blood flow than that required for these functions.  
Extrinsic mechanisms 
All blood vessels of the kidney, including afferent and efferent arterioles, are 
richly supplied by sympathetic nerve. Mild to moderate activation of 
29 
 
sympathetic activation has minor influence on renal blood flow and GFR. 
Whereas, when there is strong stimulation of the renal sympathetic plexus 
reduces the renal blood flow and GFR. For example, if there is sudden large 
drop in blood pressure due to hypovolemic shock sympathetic nervous system 
can override the renal autoregulation, constrict afferent arteriole and reduces 
GFR thereby. If still shock is not corrected the renin-angiotensin-aldosterone 
system gets activated, a hormone system which regulates blood pressure and 
fluid balance. Another hormone, atrial natriuretic peptide synthesized and 
secreted by myocytes of atrial wall when there is atrial stretching due to volume 
overload can increase the GFR and urine output. 
Renal Circulation 
Kidney receives 1.2 to 1.3 liter/ min blood (25% of cardiac output) at rest. 
Renal plasma flow equals the amount of substance excreted per unit of time 
divided by arteriovenous difference for the substance across the kidney [30]. 
𝑅𝑃𝐹 =
𝑈𝑐𝑉
𝑆𝑅𝐴𝐶 − 𝑆𝑆𝑉𝐶
 
Where, 
Uc = Concentration of substance in urine (mg/ml) 
V = Urine flow (ml/min) 
30 
 
S 
RAC
 & S 
SVC = Substance renal arterial and venous concentrations respectively. 
Renal plasma flow can be measured by infusing p- amino hippuric acid [31]. As 
excretion ratio is of PAH is high and its 90% is removed from artery in a single 
circulation through kidney and its renal arterial concentration is equal to plasma 
concentration. So renal plasma flow by PAH can also be measured by the 
formula known as effective renal plasma flow (EPRF). 
𝐸𝑅𝑃𝐹 =
𝑈𝑃𝐴𝐻 𝑉
𝑃𝐴𝐻 𝑝𝑙𝑎𝑠𝑚𝑎 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛  
 
2.3.4 Determination and Regulation of GFR 
Normal GFR is 125 ml/min or 180 L/day. So kidney filters fluid equal to 4 times 
of total body water per day. GFR, like renal blood flow, remains constant over a 
wide range of perfusing pressure from 80 – 180 mmHg due to autoregulation. 
GFR is determined by changes in net filtration pressure and glomerular capillary 
co -efficient (Kf). 
Net filtration pressure 
It is sum of hydrostatic pressure and colloid osmotic pressure across glomerular 
capillary membrane. Factors favouring filtration are glomerular capillary 
hydrostatic pressure (PG) and Bowman’s capsule colloid osmotic pressure (πG). 
Rise in glomerular capillary hydrostatic pressure increases GFR whereas, 
decrease in PG reduces GFR. PG is determined by arterial blood pressure, 
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afferent arteriolar resistance and efferent arteriolar resistance. Afferent arteriolar 
constriction caused by sympathetic stimulation or thromboxane A2 reduces 
hydrostatic pressure and GFR. Efferent arteriolar constriction caused by 
angiotensin II or ANP increase hydrostatic pressure and raises GFR. Efferent 
arteriolar constriction has a biphasic effect on GFR. Mild to moderate increase 
in resistance raises GFR but severe constriction decreases GFR. This is caused 
by nonlinear increase in colloid osmotic pressure by Donnan effect exceeding 
the PG. Auto regulatory mechanisms buffer the effects of blood pressure and 
maintain relatively constant GFR. Opposing filtration are glomerular osmotic 
pressure and Bowman’s capsule hydrostatic pressure. 
Glomerular capillary filtration co- efficient is a product of hydraulic 
conductivity (permeability) and filtering surface area of glomerular capillaries. 
𝐾𝑓 =
𝐺𝐹𝑅
𝑁𝑒𝑡 𝑓𝑖𝑙𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒
 
 GFR is increased by raising Kf   and decreased by reducing Kf  , but changes in 
filtration co – efficient do not provide a primary mechanism for regulation of 
GFR. 
Chronic uncontrolled hypertension and diabetes mellitus gradually decreases 
Glomerular capillary filtration co- efficient by increasing the glomerular 
basement membrane thickness. Increase in Bowman’s capsule hydrostatic 
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pressure (eg: ureteric obstruction) oppose hydrostatic filtering pressure and 
filtration thereby decreases GFR.  
Glomerular capillary colloid osmotic pressure is exerted by plasma proteins and 
tries to pull water into the circulation. So, it opposes filtration normally.  
Glomerular filtrate is essentially protein free because glomerular capillaries are 
relatively impermeable to proteins. This results in almost zero colloid osmotic 
pressure. Therefore glomerular oncotic pressure is much higher than that of 
glomerular filtrate in Bowman’s capsule. Conditions causing fall in plasma 
protein concentration such as nephrotic syndrome and cirrhosis of liver 
decreases glomerular plasma oncotic pressure.  
Water and electrolyte homeostasis by kidney 
When the urine is dilute, water is excreted in excess of solutes. Conversely, 
when urine is concentrated, solutes are excreted in excess of water. Renal 
clearance is the rate at which plasma is cleared of water (free water clearance) 
and solutes (osmotic clearance) each minute. Osmotic clearance is calculated by 
dividing rate of osmotic clearance and plasma osmolarity. 
 𝑂𝑠𝑚𝑜𝑡𝑖𝑐 𝑐𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒 =
𝑈𝑟𝑖𝑛𝑒 𝑜𝑠𝑚𝑜𝑙𝑎𝑟𝑖𝑡𝑦 𝑋 𝑈𝑟𝑖𝑛𝑒 𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒
𝑃𝑙𝑎𝑚𝑎 𝑜𝑠𝑚𝑜𝑙𝑎𝑟𝑖𝑡𝑦
 
 
Antidiuretic hormone (ADH) a peptide hormone synthesized by hypothalamus, 
stored and secreted by posterior pituitary has impact on diluting and 
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concentrating ability of kidneys. Most important action of ADH on kidneys is to 
facilitate the permeability of collecting duct to water and to increase the 
permeability medullary collecting duct to urea. It also stimulates reabsorption of 
sodium chloride by thick ascending limb of loop of henle, distal tubule and 
collecting duct. 
 
ADH exerts its antidiuretic effect by binding and activating vasopressin 2 
receptors on basolateral membrane of principal cell of late distal tubule and 
collecting duct [33]. ADH binding to vasopressin 2 receptors increases cyclic 
AMP and stimulates protein kinase A eventually resulting in insertion aquaporin 
2 (water channel) containing vesicles into the apical membrane of cell. With 
removal of ADH aquaporin channels are internalized into the cell and apical 
membrane again becomes impermeable to water. This transportation of water 
channels into and out of apical membrane regulates its permeability to water. 
Free water clearance is the volume of plasma cleared of solute free water each 
minute. It is calculated as the difference between water excretion and osmotic 
clearance [32]. It can be positive, negative or zero. Positive means kidneys are 
forming dilute urine. When water is removed from plasma in excess of solutes 
and plasma is being concentrated. In negative free water clearance urine 
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osmolarity is more than the plasma osmolarity indicating water conservation. In 
zero free water clearance kidneys produce urine osmotic to plasma.  
 
In addition to controlling total volume, the plasma osmolarity is also tightly 
regulated by kidneys. Extreme variation in osmolarity destroys cell structure and 
function. This is achieved by matching the intake and excretion of sodium with 
water. Regulation of osmolarity must be combined with regulation of volume, 
because changes in water volume alone have concentrating or diluting effects on 
the body fluids. If there is dehydration kidney excrete proportionately more 
water than solute, so that osmolarity of body fluid increases. Body must 
conserve water but not sodium. By increasing osmolarity, ADH and thirst 
mechanism comes into action, thus conserving water. If there is large amount of 
blood loss body should conserve both water and sodium. 
Sodium reabsorption occurs in all segments of nephron except descending limb 
of loop of henle. Sodium is actively transported into the interstitium by 
Na+K+ATPase. Major portion (60%) of sodium reabsorption occurs in proximal 
convoluted tubule. About 7% of sodium absorption occurs in distal convoluted 
tubule for which aldosterone is needed. Aldosterone is secreted by adrenal 
cortex causes water and sodium reabsorption from distal convoluted tubule. 
ADH plays a major role in decreasing osmolarity by increasing water 
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reabsorption in the kidneys, thus dilutes body fluids. To avoid osmolarity from 
falling below normal, the kidneys also have a mechanism for reabsorbing 
sodium in the distal nephron. This mechanism is under the control 
of aldosterone, a steroid hormone secreted by the adrenal cortex. Aldosterone 
secretion is under the control of following mechanisms. When 
the osmolarity increases above normal, sensed by adrenal cortex which inhibits 
aldosterone secretion. In the absence of aldosterone less sodium is reabsorbed in 
the distal convoluted tubule. ADH secretion will also increase to conserve water, 
thus supplementing the effect of low aldosterone levels to reduce the osmolarity. 
The net effect is decreased urine output with more urine osmolarity. 
Renin an acid protease which converts angiotensinogen to angiotensin I is 
secreted from distal convoluted tubule of kidney. Increased GFR reduces renin 
secretion. Angiotensin converting enzyme present in endothelium of lung 
capillaries converts angiotensin I into angiotensin II. It increases aldosterone 
secretion resulting in increased sodium and water reabsorption. It is a potent 
arteriolar constrictor resulting in rise in blood pressure and total peripheral 
resistance. In the kidney angiotensin II causes afferent arteriolar constriction, 
shrinkage of mesangial cells with resultant decrease in GFR [29]. It is 
dipsogenic , increases secretion of vasopressin(ADH) and ACTH and decreases 
renin secretion. In renal failure both these homeostatic mechanisms are 
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disturbed and severe abnormalities in fluid volume and electrolytes occur. There 
will be accumulation of fluid, acid, potassium and other waste products. Unless 
interventions have been initiated to restore renal function either completely or 
partially, death can occur. 
 
 
 
 
 
                                                                                
 
 
 
 
 
2.3.5 Kidney diseases 
Kidney diseases are among the most important cause of morbidity and mortality 
in many countries all over the world. Unfortunately, in India limited data 
available on the prevalence of CKD due to lack of proper longitudinal study. A 
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study published in Indian journal of nephrology in 2015 conducted from a rural 
belt of Karnataka   was found that high prevalence of hypertension and renal 
disease in younger age groups (mean age was around 40 years) and low 
prevalence of diabetes mellitus surprisingly. Unfortunately, they found high 
prevalence (6.3%) of stage 3 chronic kidney disease which is the highest report 
till date [34]. Kidney diseases could be divided into Acute and Chronic Renal 
Failure. 
i) Acute Renal Failure (ARF): 
Acute renal failure is defined as a rapid, potentially reversible deterioration in 
renal function sufficiently enough to cause accumulation of nitrogenous waste 
products in the body results in [35]. (a) An increase in serum creatinine of ≥ 0.3 
mg/ dl within 48 hours, or (b) An increase in serum creatinine of ≥ 1.5 times 
baseline which is known or presumed to have occurred within the prior seven 
days, or (c)  Urine volume < 0.5 ml/ kg/ hour for more than six hours. 
Presently, the term acute kidney injury (AKI) is often used in place of acute 
renal failure. The term ARF is used for the group of population who need 
dialysis support. RIFLE criteria are used to classify severity of AKI. RIFLE 
stands for Risk, Injury, Failure, Loss and End stage renal disease [36].  
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Table 5 RIFLE criteria 
Stages Glomerular filtration criteria/ 
serum creatinine 
Urine output 
criteria 
Risk Increased s-creatinine x 1.5 or  
GFR decrease >25% 
UO < 0.5 ml/kg/h 
for 6 hours 
Injury Increased s-creatinine x 2 or GFR 
decreased >50% 
UO < 0.5 ml/kg/h 
for 12 hours 
Failure Increased s-creatinine x 3 or GFR 
decrease >75% or 
s-creatinine ≥320 µmol/l 
Acute rise ≥40 µmol/d 
UO < 0.3 ml/kg/h 
for 24 hours 
(Oliguria) or 
Anuria x 12 hrs 
 Dialysis dependence  
Loss Persistent Acute Kidney Injury = 
complete loss of kidney 
function/dialysis dependent > 4 
weeks 
 
End stage 
renal 
disease 
End-stage renal disease/ dialysis 
dependent for >3 months 
 
 
 
Acute Kidney Injury Network (AKIN) classification: AKI is classified into three 
stages. (a) Stage 1 is same as Risk category of RIFLE with addition of increase 
in serum creatinine by 0.3 mg/ dl. (b) Stage 2 and 3 are same as Injury and 
Failure categories of RIFLE. 
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Acute renal failure is classified into (a) Prerenal – Kidneys are inadequately 
perfused either due to decreased cardiac output or loss of body fluid. GFR is 
greatly diminished resulting in oliguria. (b) Renal – Resulting from intrinsic 
diseases of the kidneys themselves, such as glomerular, tubulo-interstitial or 
vascular diseases. In acute tubular necrosis, a diminution in oxygen and nutrient 
supply to the tubular cells result in ischemia and necrosisof the tubular cells. 
Fortunately, the tubular cells can regenerate when causative factors are removed. 
(c) Post-renal: ARF is caused by an obstruction of the urinary tract at any point 
in its course. 
In pre renal AKI patients usually presents with hypotension, poor peripheral 
perfusion and a falling urine output. ATN is the most important cause of ARF 
due to intrinsic renal disease. The clinical course of ATN can be divided into an 
oliguric phase, maintenance phase and a diuretic phase. Not all patients with 
ATN develop oliguric failure. Around 40% of the patients may have normal 
urine output. This is called non oliguric renal failure. The electrolyte 
disturbances are less in these patients. Patients with glomerulonephritis typically 
have hypertension, proteinuria and hematuria. Bilateral post renal obstruction 
commonly causes anuria. Patient can have loin pain, hematuria and renal colic. 
Patients with ARF due to any cause may also symptoms related to uremia. 
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Table 6 Causes of Acute Renal Failure 
Pre Renal Renal Post Renal 
1. Hypovolemia due 
to diarrhoea, fever 
and bleeding 
 
2. Cardiac Failure  
 
3.Hepatorenal 
syndrome 
 
4.Renal artery 
occlusion  
 
5. Rhabdomyolysis 
 
6. Haemolysis 
 
7. Severe sepsis 
 
1. Glomerulonephritis 
including vasculitis 
 
2. Interstitial nephritis 
due to infections, 
drugs, intoxications 
 
3.Hereditary 
disturbances such as 
Polycystic kidney 
disease (acute 
bleeding) 
 
4. Transplant kidney 
rejection 
1. Prostatic obstruction 
 
2. Urinary tract obstruction 
(tumour, blood clots or 
stones) 
 
3. Urinary retention due to 
dysfunction in detrusor by 
drugs and denervation 
 
4. Pyelonephritis and 
urosepsis 
 
These include anorexia, nausea, vomiting, pruritis, uremic encephalopathy and 
dyspnea due to fluid overload. In acute kidney injury haemoglobin is usually 
normal, and the kidneys size may be normal or large. Biomarkers are available 
to diagnose AKI early [38]. These are gelatinase – associated lipocalin (NGAL), 
kidney injury molecule – 1(KIM-1), interlukin18 and cystatin C. 
Management of AKI: Therapy for AKI is directed at correcting fluid and 
electrolyte abnormalities, treating the underlying cause and preventing 
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complications including nutritional deficiencies. An attempt should be made to 
identify the cause and to correct it if possible. Administer a challenge of fluid 
intravenously in patients with clinical history consistent with fluid loss and 
physical examination consistent with hypovolemia. Emergency treatment should 
be started for hyperkalemia to prevent life threatening complications. Acidosis 
should be treated with intravenous or oral bicarbonate if serum bicarbonate level 
is < 15 mEq/L. After correction of fluid deficit, maintain a daily fluid intake 
equal to the amount of urine output plus 400 – 500 ml to balance the insensible 
loss. Dietary protein should be constrained to about 40 g/ day. Attempts can be 
made to suppress endogenous protein catabolism to a minimum by giving as 
much energy as possible in the form of carbohydrates and fats. Salt should also 
be restricted. Nephrotoxic drugs should be avoided. Patients with RPGN are 
treated with corticosteroids and cyclophosphamide. If conservative measures 
fail, hemodialysis may be required. 
1. Indications of Hemodialysis 
2. Symptomatic uremia with high blood urea 
3. Resistant hyperkalemia 
4. Uremic pericarditis 
5. Refractory pulmonary edema 
6. Severe metabolic acidosis 
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7. Uremic encephalopathy 
Patients recovered from acute kidney injury should be followed up periodically 
[38], because an episode of AKI can increase the risk of developing chronic 
kidney disease and other cardiovascular complications such as myocardial 
infarction and cerebrovascular accident in future. Many studies found that AKI 
patients not only having increased risk of future cardiovascular complications, 
mortality is also high in patients having myocardial infarction along with renal 
dysfunction.  Though acute cerebrovascular accident is a common disease and 
shares the similar atherosclerotic risk factors with ischemic heart disease, the 
association of stroke and renal function is poorly investigated. 
ii) Chronic Kidney Disease 
Chronic kidney disease is defined as GFR < 60 ml/ min/ 1.73 m2 body surface 
areas due to abnormalities of kidney structure or function, present more than 3 
months with implications for health [48].  Kidney damage for ≥ 3months with or 
without decreased GFR, as evidenced by any of the following: 
1. Microalbuminuria (urine albumin excretion 30 – 300 mg/ day) 
2. Macroalbumiuria (urine albumin > 300 mg/ day) 
3. Persistent hematuria (where other causes such as urologic conditions have 
been excluded) 
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4. Urine sediment abnormalities 
5. Electrolyte abnormalities  
6. Radiological abnormalities such as scarring or polycystic kidneys on 
ultrasound 
7. Abnormal renal biopsy 
8. History of transplantation 
Major outcomes of renal dysfunction are progression of kidney failure, 
complications from decreased kidney function and development of 
cardiovascular disease including stroke. Cardiovascular events are more 
common than renal failure. The purpose of the present study is to investigate the 
role of renal function in patients with acute stroke on overall outcome. 
Therapeutic interventions in the earlier stages may prevent or reduce some of 
these complications including progression to kidney failure.  Risk factors for 
developing renal dysfunction are older age, family history of kidney disease, 
poor glycemic control in diabetes mellitus, hypertension, autoimmune disease, 
systemic infections, UTI, obstructive uropathy, nephrotoxic drugs and smoking.  
2.3.6 Assessment of renal function 
Usually renal function has been assessed by blood urea and serum creatinine in 
daily clinical practice. However, these investigations do not give an accurate 
measure of the renal clearance as glomerular filtration rate (GFR). 
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Urea: Urea is the principle waste product of protein and amino acid metabolism.  
 
Fig 6 Molecular formula of urea 
Proteins are metabolized into amino acids, which are consecutively deaminated 
with production of ammonia which is toxic. Then ammonia is entered into a 
series of reactions in hepatocytes known as urea cycle and converted into less 
toxic urea which is excreted mostly by kidneys. Increased urea production is 
associated with increased protein catabolism such as diet rich in protein, tissue 
protein breakdown during starvation or any other pathology. Urea is both 
secreted and reabsorbed in renal tubule. So, the net effect is around 30 – 40% of 
the filtered urea appears in urine. 
Blood Urea Nitrogen: Molecular weight of urea (CO(NH2)2 is 60 (C -12, 2N – 
28, O – 16, 4H - 4). Only nitrogen content of urea known as blood urea nitrogen 
(MW – 28) is approximately half of the urea. 
Creatinine: Creatine is an endogenously formed molecule that is stored mainly 
in skeletal muscle, in both free and phosphorylated forms. The phosphorylated 
form is named as creatine phosphate.  
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Fig 7 Molecular formula of creatinine 
Creatinine is a non-protein nitrogenous breakdown constituent of creatine 
phosphate produced in kidney, liver and pancreas. Generally it is synthesized at 
a fairly constant rate depending on muscle mass and excreted predominantly by 
the kidneys by glomerular filtration and tubular secretion. Little or no tubular 
reabsorption. If there is defect in renal filtration serum creatinine levels will be 
increased. Serum creatinine is most commonly used investigation to assess the 
renal function. But this may not be accurate due to various reasons like age, sex, 
race and body mass. 
eGFR Estimation 
Measuring GFR is challenging to perform practically which has been explained 
in previous chapter. Hence, eGFR is often derived from serum creatinine using 
following equations [49, 50]. 
𝑀𝐷𝑅𝐷 𝑒𝐺𝐹𝑅 = 186 × [ 𝑃𝑙𝑎𝑠𝑚𝑎 𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑒 (µ𝑚𝑜𝑙/𝐿) × 0.0011312]−1.154 × [ 𝑎𝑔𝑒(𝑦𝑒𝑎𝑟𝑠)]−0..203 
× [0.742 𝑖𝑓 𝑓𝑒𝑚𝑎𝑙𝑒] × [1.212 𝑖𝑓 𝑏𝑙𝑎𝑐𝑘] 
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𝑀𝐷𝑅𝐷 𝑒𝐺𝐹𝑅(𝐼𝐷𝑀𝑆 𝑎𝑙𝑖𝑔𝑛𝑒) =  175 × [ 𝑃𝑙𝑎𝑠𝑚𝑎 𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑒 (µ𝑚𝑜𝑙/𝐿) × 0.0011312]−1.154  
× [ 𝑎𝑔𝑒(𝑦𝑒𝑎𝑟𝑠)]−0..203 × [0.742 𝑖𝑓 𝑓𝑒𝑚𝑎𝑙𝑒] × [1.212 𝑖𝑓 𝑏𝑙𝑎𝑐𝑘] 
𝐶𝐾𝐷 − 𝐸𝑃𝐼 𝑒𝐺𝐹𝑅; 
  𝐹𝑒𝑚𝑎𝑙𝑒 𝑤𝑖𝑡ℎ 𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑒 < 62 (𝜇𝑚𝑜𝑙/𝐿); 𝑢𝑠𝑒 𝑒𝐺𝐹𝑅 = 144 × (𝐶𝑟/61.6)−0.329 
 
× (0.993)𝑎𝑔𝑒  
  𝐹𝑒𝑚𝑎𝑙𝑒 𝑤𝑖𝑡ℎ 𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑒 > 62 (𝜇𝑚𝑜𝑙/𝐿); 𝑢𝑠𝑒 𝑒𝐺𝐹𝑅 = 144 × (𝐶𝑟/61.6)−1.209 
 
× (0.993)𝑎𝑔𝑒  
  𝑀𝑎𝑙𝑒 𝑤𝑖𝑡ℎ 𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑒 < 80 (𝜇𝑚𝑜𝑙/𝐿); 𝑢𝑠𝑒 𝑒𝐺𝐹𝑅 = 141 × (𝐶𝑟/79.2)−0.411 
 
× (0.993)𝑎𝑔𝑒  
  𝑀𝑎𝑙𝑒 𝑤𝑖𝑡ℎ 𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑒 > 80 (𝜇𝑚𝑜𝑙/𝐿); 𝑢𝑠𝑒 𝑒𝐺𝐹𝑅 = 141 × (𝐶𝑟/79.2)−1.209 
 
× (0.993)𝑎𝑔𝑒  
2.3.6 Unrecognized renal dysfunction 
Though renal dysfunction has clinically signiﬁcant impact on outcome of 
cardiovascular disorders, it is often missed because renal function is assessed 
routinely by serum creatinine. A significant percentage of patients with normal 
serum creatinine levels or slightly above the normal range have reduced renal 
function, which may often be clinically signiﬁcant. Hence, the term 
unrecognized renal dysfunction, is deﬁned as an estimated glomerular ﬁltration 
rate <60 mL/min/1.73 m2 in the presence of normal serum creatinine. This is a 
common comorbidity among patients with various cardiovascular diseases 
including stroke (ischemic and hemorrhagic) which has not been studied 
extensively. Unrecognized renal insufﬁciency has also been strongly associated 
with adverse outcomes in patients with cardiovascular disorders [2].  This is 
more frequently seen in elderly and females patients. This can be explained by 
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the frailty and lower muscle mass of these patients that may result in signiﬁcant 
renal dysfunction with normal serum creatinine levels.   
2.4 Renal dysfunction and cerebrovascular accident 
Chronic kidney disease stage ≥2 is an important risk factor for cardiovascular 
diseases including stroke. The Cardiovascular Health Study has shown that 
patients aged more than 65 years with raised serum creatinine were associated 
with greater mortality from cardiovascular disease compared to patients with 
normal creatinine (3.6% vs 1.3%) [1]. HOPE study has reported that even mild 
renal dysfunction was associated with increased risk of stroke. Furthermore, 
reduced eGFR was associated with increased risk of death and cardiovascular 
events. On the other hand, renal dysfunction may correlate with endothelial 
dysfunction since patients with chronic kidney disease stage 5 have increased 
arterial stiffness which in turn is an independent risk factor for atherosclerosis 
[3]. Even mild to moderate renal dysfunction is associated with central artery 
stiffness, signifying that renal insufficiency adversely affect small and large 
arteries. Epidemiological study demonstrated that renal insufficiency forecast 
long-term mortality and hence can be used to stratify risk for stroke patients. A 
stroke treatment guideline recommends that urea and creatinine values are 
important in the acute condition [3, 1, 2]. Latest study involved 7900 patients 
with acute stroke included in the prospective National Acute Stroke ISraeli 
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registry established that unrecognized renal dysfunction is more common and is 
associated with adverse short term outcomes among patients with acute stroke 
[2]. This study also reported mortality rates are higher in patients with 
unrecognized and recognized renal insufﬁciency compared with patients with 
normal renal function (9.1%, 9.9%, and 4.4%, respectively). However, the 
outcome of stroke patients whether improves with intervention to prevent or 
treat renal dysfunction is not yet known.  
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AIMS AND OBJECTIVES 
The aim of this study is  
To determine the prevalence of the unrecognized renal insufﬁciency in patients 
admitted with acute stroke and its clinical significance.  
To evaluate role of unrecognized renal insufficiency as a risk factor contributing 
to short term mortality. 
 
MATERIAL & METHODS 
 
Study design: Cross sectional study 
Study center: Stanley Government Medical College, Chennai 
Study duration: March 2017 to August 2017 
Inclusion criteria: All patients admitted with acute stroke                              
Exclusion criteria: Acute stroke in < 18 years 
                                 Head injury 
Methodology:  
The study group consisted of 100 patients with acute stroke admitted in Stanley 
Govt. Medical College. Stroke is defined as abrupt onset of neurological deficit.  
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The detailed history of the patients has been recorded and patients underwent a 
detailed clinical examination.  
Hemogram, Metabolic profile, chest radiography, ecg and brain imaging (CT / if 
needed MRI brain) were done in all patients.  
The estimated glomerular ﬁltration rate is calculated using the simpliﬁed 
Modiﬁcation of Diet in Renal Disease formula and Chronic Kidney Disease 
Epidemiology Collaboration equation.  
The study groups are stratiﬁed into 3 groups according to the renal function 
assessment (normal renal Function, unrecognized renal insufﬁciency, and 
recognized renal insufﬁciency). 
Unrecognized renal insufﬁciency is deﬁned as an estimated glomerular ﬁltration 
rate <60 mL/min/1.73 m
2 
in the presence of serum creatinine 1.2 mg/dL. 
MDRD formula:  
 
186×[serum creatinine (mg/ dl)] – 1.154×[age in years]– 0.203. 
For women, the product of this equation was multiplied by a factor of 0.742. 
 
The two primary outcomes are in-hospital mortality and severe disability at 
discharge in 3 groups are estimated and compared within 3 groups. 
Ethical Committee Approval: Approval was obtained for this study. 
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RESULT AND DISCUSSION 
 
Study Subjects 
 
 
 
Study Subjects 
Normal Renal 
Function 
Unrecognized Renal 
Insufficiency 
Recognized Renal 
Insufficiency 
Number 62 7 31 
Percentage 62% 7% 31% 
 
Out of the 100 patients with acute stroke included in the study, 62 (62%) have 
normal renal function, 31 (31%) have recognized renal insufﬁciency, and 7 (7%) 
have unrecognized renal insufﬁciency.  
62, 62% 
7, 7% 
31, 31% 
Normal Renal Function
Unrecognized Renal
Insufficiency
Recognized Renal Insufficiency
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Age 
 
 
 
Age 
Groups 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
≤ 40 years 4 6.45 0 0.00 2 6.45 
41-60 
years 
33 53.23 2 28.57 14 45.16 
61-80 
years 
25 40.32 4 57.14 15 48.39 
> 80 years 0 0.00 1 14.29 0 0.00 
Total 62 100.00 7 100.00 31 100.00 
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Age Distribution 
Normal Renal 
Function 
Unrecognized Renal 
Insufficiency 
Recognized Renal 
Insufficiency 
Mean 57.19 68.29 58.97 
SD 8.97 10.92 9.67 
P value Single  
Factor ANOVA Test 
0.0135 
 
Results 
While analyzing age distribution in relation to renal function among stroke 
patients, it was observed that majority of the study subjects in normal renal 
function group were distributed in 41-60 years age group (n=33, 53.23%), 61-80 
years age group in unrecognized renal insufficiency group (n=4, 57.14%) and 
recognized renal insufficiency group (n=15, 48.39%). 
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Discussion  
When the age distribution between three groups was analysed statistically using 
single factor ANOVA test,  the difference in the mean age of patients in normal 
renal function group (57.19), unrecognized renal insufficiency group (68.29) and 
recognized renal insufficiency group (58.97) was found to be statistically 
significant (p < 0.05).  
Conclusion  
We can conclude that unrecognized renal insufficiency among stroke patients is 
found significantly common among older age group in our study group.  
 
Gender  
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Gender 
status 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Male 48 77.42 0 0.00 24 77.42 
Female 14 22.58 7 100.00 7 22.58 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
<0.0001 
 
Results 
While analyzing gender status in relation to renal function among stroke 
patients, it was observed that majority of the study subjects in normal renal 
function group were males (n=48), females in unrecognized renal insufficiency 
group (n=7) and males in recognized renal insufficiency group (n=24). 
Discussion  
When the gender status between three groups was analysed statistically using 
fishers exact test, the difference in percentage of females in normal renal 
function group (22.58%), unrecognized renal insufficiency group (100.00%) and 
recognized renal insufficiency group (22.58%) was found to be statistically 
significant (p <0.05). it is evident that there is a statistically significant increase 
in incidence of unrecognized renal insufficiency in females compared to males. 
Conclusion  
We can conclude that unrecognized renal insufficiency among stroke patients is 
found significantly common among females compared to males in our study 
group.  
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Type of Stroke 
 
 
Type of 
Stroke 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Infarct 50 80.65 6 85.71 19 61.29 
Hemorrhage 12 19.35 1 14.29 12 38.71 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
0.1171 
 
Results 
While analyzing type of stroke in relation to renal function among stroke 
patients, it was observed that majority of the study subjects had infarct in normal 
renal function group (n=50), in unrecognized renal insufficiency group (n=6) 
and in recognized renal insufficiency group (n=19). 
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Discussion  
When the type of stroke between three groups was analysed statistically using 
fishers exact test,  the difference in percentage of infarct type  in normal renal 
function group (80.65%), unrecognized renal insufficiency group (85.71%) and 
recognized renal insufficiency group (61.29%) was found to be statistically 
insignificant (p >0.05).  
Conclusion  
In a study conducted in Medical University of Bialystok, Poland found that 
patients with hemorrhagic stroke experienced more worsening of renal function 
compared to ischemic stroke [1]. But in our study we found that variable type of 
stroke is normally distributed across the three study groups and has no bearing 
on renal function among stroke patients. 
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Systolic Hypertension 
 
 
Presence of 
Systolic 
Hypertension 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Yes 42 67.74 4 57.14 24 77.42 
No 20 32.26 3 42.86 7 22.58 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
0.4631 
 
Results 
While analyzing incidence of hypertension in relation to renal function among 
stroke patients, it was observed that majority of the study subjects had 
hypertension in normal renal function group (n=42), in unrecognized renal 
insufficiency group (n=4) and in recognized renal insufficiency group (n=24). 
 
 
42 
4 
24 
20 
3 
7 
0
5
10
15
20
25
30
35
40
45
Normal Renal Function Unrecognized Renal
Insufficiency
Recognized Renal
Insufficiency
Presence of Systolic Hypertension 
Yes No
59 
 
Discussion  
When the hypertension status between three groups was analysed statistically 
using fishers exact test,  the difference in percentage of subjects with 
hypertension  in normal renal function group (67.64%), unrecognized renal 
insufficiency group (57.14%) and recognized renal insufficiency group 
(77.42%) was found to be statistically insignificant (p >0.05).  
Conclusion  
We can conclude that the variable hypertension is normally distributed across 
the three study groups and has no bearing on renal function among stroke 
patients. 
 
Diabetes Mellitus 
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Presence 
of 
Diabetes 
Mellitus 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Yes 12 19.35 1 14.29 18 58.06 
No 50 80.65 6 85.71 13 41.94 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
0.0005 
 
Results 
While analyzing incidence of diabetes mellitus in relation to renal function 
among stroke patients, it was observed that majority of the study subjects were 
non diabetics in normal renal function group  (n=50) and in unrecognized renal 
insufficiency group (n=6) and diabetics in recognized renal insufficiency group 
(n=18). 
Discussion  
When the diabetes mellitus status between three groups was analysed 
statistically using fishers exact test,  the difference in percentage of diabetics in 
normal renal function group (19.35%), unrecognized renal insufficiency group 
(14.29%) and recognized renal insufficiency group (58.06%) was found to be 
statistically significant (p <0.05). It is evident that there is a statistically 
significant increase in incidence of diabetes in recognized renal insufficiency 
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group compared to normal renal function group (67% increase) and  
unrecognized renal insufficiency group (75% increase) 
Conclusion  
We can conclude that recognized renal insufficiency among stroke patients is 
found significantly common among diabetics in our study group.  
Coronary Artery Disease 
 
 
 
Presence 
of 
Coronary 
Artery 
Disease 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Yes 5 8.06 0 0.00 2 6.45 
No 57 91.94 7 100.00 29 93.55 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
>0.9999 
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Results 
While analyzing incidence of coronary artery disease in relation to renal 
function among stroke patients, it was observed that majority of the study 
subjects had no coronary artery disease in normal renal function group (n=57), 
in unrecognized renal insufficiency group (n=7) and in recognized renal 
insufficiency group (n=29). 
Discussion  
When the coronary artery disease status between three groups was analysed 
statistically using fishers exact test,  the difference in percentage of subjects with 
coronary artery disease  in normal renal function group (8.00%), unrecognized 
renal insufficiency group (0.00%) and recognized renal insufficiency group 
(6.45%) was found to be statistically insignificant (p >0.05).  
Conclusion  
In our study we found that prevalence of coronary artery disease is low (7%) and 
it is normally distributed across the three study groups and has no bearing on 
renal function among stroke patients. 
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Dyslipidemia 
 
 
Dyslipidemia 
Status 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Yes 22 35.48 6 85.71 21 67.74 
No 40 64.51 1 14.28 10 32.25 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
0.0014 
 
Results 
While analyzing incidence of dyslipidaemia in relation to renal function among 
stroke patients, it was observed that majority of the study subjects had 
dyslipidaemia  in normal renal function group (n=22), in unrecognized renal 
insufficiency group (n=6) and in recognized renal insufficiency group (n=21). 
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Discussion  
When the dyslipidemia status between three groups was analysed statistically 
using fishers exact test,  the difference in percentage of subjects with 
dyslipidemia in normal renal function group (35.48%), unrecognized renal 
insufficiency group (85.71%) and recognized renal insufficiency group 
(67.74%) was found to be statistically significant (p < 0.05).  
Conclusion  
We can conclude that dyslipidemia among stroke patients is found significantly 
common in both unrecognized and recognized renal insufficiency compared 
with patients having normal renal function in our study group.  
 
Smoking Status 
 
 
31 
0 
15 
31 
7 
16 
0
5
10
15
20
25
30
35
Normal Renal Function Unrecognized Renal Insufficiency Recognized Renal Insufficiency
Yes No
65 
 
Smoking 
Status 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Yes 31 50.00 0 0.00 15 48.39 
No 31 50.00 7 100.00 16 51.61 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
0.3051 
 
Results 
While analyzing incidence of smoking in relation to renal function among stroke 
patients, it was observed that majority of the study subjects were non smokers in 
normal renal function group (n=31), in unrecognized renal insufficiency group 
(n=7) and in recognized renal insufficiency group (n=16). 
Discussion  
When the smoking status between three groups was analysed statistically using 
fishers exact test,  the difference in percentage of subjects with smoking habit in 
normal renal function group (50.00%), unrecognized renal insufficiency group 
(0.00%) and recognized renal insufficiency group (48.39%) was found to be 
statistically insignificant (p >0.05).  
Conclusion  
We can conclude that the variable smoking is normally distributed across the 
three study groups. Hence, relation between smoking and renal dysfunction is 
statistically insignificant in our study. 
66 
 
Alcohol Intake 
 
 
Alcohol 
Intake 
Status 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
Yes 33 53.23 0 0.00 16 51.61 
No 29 46.77 7 100.00 15 48.39 
Total 62 100.00 7 100.00 31 100.00 
P value 
Fishers Exact Test 
0.2334 
 
Results 
While analyzing incidence of alcohol intake in relation to renal function among 
stroke patients, it was observed that majority of the study subjects were 
alcoholics in normal renal function group (n=33), in recognized renal 
insufficiency group (n=16) and non-alcoholics in unrecognized renal 
insufficiency group (n=7). 
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Discussion  
When the alcohol intake status between three groups was analysed statistically 
using fishers exact test,  the difference in percentage of alcoholic subjects in 
normal renal function group (52.33%), unrecognized renal insufficiency group 
(0.00%) and recognized renal insufficiency group (51.61%) was found to be 
statistically insignificant (p >0.05).  
Conclusion  
We can conclude that the variable alcohol intake is normally distributed across 
the three study groups and has no bearing on renal function among stroke 
patients. 
Renal Parameters 
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Renal Parameters Blood Urea 
Serum 
Creatinine 
Normal Renal Function 
Mean 26.19 0.89 
SD 8.58 0.17 
Unrecognized Renal Insufficiency 
Mean 32.29 1.14 
SD 6.97 0.10 
Recognized Renal Insufficiency 
Mean 40.19 1.55 
SD 19.57 0.28 
P value 
Single Factor ANOVA Test 
<0.0001 <0.0001 
 
Results 
While analyzing renal parameters in relation to renal function among stroke 
patients, the observed mean blood urea levels were 26.19 in normal renal 
function group, 32.29 in unrecognized renal insufficiency group and 40.19 in 
recognized renal insufficiency group. Similarly the observed mean serum 
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creatinine levels were 0.89 in normal renal function group, 1.14 in unrecognized 
renal insufficiency group and 1.55 in recognized renal insufficiency group 
Discussion  
When the renal parameters distribution between three groups was analysed 
statistically using single factor ANOVA test,  the mean difference of blood urea 
values in unrecognized renal function group compared to normal renal function 
group was 6.09 (19 % increase) and between recognized renal insufficiency 
group compared to unrecognized renal insufficiency group was 7.91 (20 % 
increase).  This was found to be statistically significant (p <0.05). Similarly the 
mean difference of serum creatinine values in unrecognized renal function group 
compared to normal renal function group was 0.25 (22% increase) and between 
recognized renal insufficiency group compared to unrecognized renal 
insufficiency group was 0.41 (26 % increase).  This was found to be statistically 
significant (p <0.05). 
 
It is evident that there is a statistically significant progressive increase in renal 
parameters across the three groups. On calculating the effect size of blood urea 
using Cohen’s “d” value (d = 1.19), a high practical significance was observed 
(88% of study subjects with blood urea levels over 40 will have recognized renal 
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insufficiency and 69% of study subjects with blood urea levels between 32-40 
will have unrecognized renal insufficiency). 
 
Similarly on calculating the effect size of serum creatinine using Cohen’s “d” 
value (d = 3.00), a high practical significance was observed (100% of study 
subjects with serum creatinine levels over 1.55 will have recognized renal 
insufficiency and 90% of study subjects with serum creatinine between 1.14-
1.55 will have unrecognized renal insufficiency) . 
Conclusion  
We can conclude that blood urea and serum creatinine levels are low in patients 
with normal renal function compared with unrecognized renal insufficiency and 
recognized renal insufficiency. 
EFGR 
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Estimated Glomerular Filtration Rate Calculation MDRD CKD-Epi 
Normal Renal Function 
Mean 92.51 89.38 
SD 19.58 14.32 
Unrecognized Renal Insufficiency 
Mean 50.71 49.50 
SD 4.07 3.28 
Recognized Renal Insufficiency 
Mean 47.95 47.47 
SD 10.65 10.87 
P value 
Single Factor ANOVA Test 
<0.0001 <0.0001 
 
Results 
While analyzing eGFR parameters in relation to renal function among stroke 
patients, the observed mean MDRD levels were 92.51 in normal renal function 
group, 50.71 in unrecognized renal insufficiency group and 47.95 in recognized 
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renal insufficiency group. Similarly the observed mean CKD-EPI levels were 
89.38 in normal renal function group, 49.50 in unrecognized renal insufficiency 
group and 47.47 in recognized renal insufficiency group 
Discussion  
When the eGFR parameters distribution between three groups was analysed 
statistically using single factor ANOVA test,  the mean difference of MDRD 
values in unrecognized renal function group compared to normal renal function 
group was 41.80 (82 % decrease) and between recognized renal insufficiency 
group compared to unrecognized renal insufficiency group was 2.77 (6 % 
decrease).  This was found to be statistically significant (p <0.05).  
 
Similarly the mean difference of CKD-EPI values in unrecognized renal 
function group compared to normal renal function group was 59.88 (81% 
decrease) and between recognized renal insufficiency group compared to 
unrecognized renal insufficiency group was 2.03 (4 % decrease).  This was 
found to be statistically significant (p <0.05). 
 
It is evident that there is a statistically significant progressive increase in eGFR 
parameters across the three groups. On calculating the effect size of MDRD 
using Cohen’s “d” value (d = 3.00), a high practical significance was observed 
(100% of study subjects with MDRD levels under 47.95 will have recognized 
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renal insufficiency and 81% of study subjects with MDRD levels between 51-48 
will have unrecognized renal insufficiency) . 
 
Similarly on calculating the effect size of CKD-EPI using Cohen’s “d” value 
(d = 3.00), a high practical significance was observed (100% of study subjects 
with CKD-EPI levels under 47.47 will have recognized renal insufficiency and 
86% of study subjects with CKD-EPI between 50-47 will have unrecognized 
renal insufficiency). 
Conclusion  
We can conclude that MDRD and CKD-EPI levels were significantly lower in 
patients with recognized renal insufficiency compared with unrecognized renal 
insufficiency. 
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Hemodynamic Measurements 
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Hemodynamic Measurements SBP DBP 
Normal Renal Function 
Mean 152.74 85.97 
SD 27.29 11.66 
Unrecognized Renal 
Insufficiency 
Mean 148.57 91.43 
SD 18.64 10.69 
Recognized Renal 
Insufficiency 
Mean 161.61 90.97 
SD 23.39 14.46 
P value 
Single Factor ANOVA Test 
<0.0001 <0.0001 
 
Results 
While analyzing hemodynamic parameters in relation to renal function among 
stroke patients, the observed mean SBP was 152.74 in normal renal function 
group, 148.57 in unrecognized renal insufficiency group and 161.67 in 
recognized renal insufficiency group and observed DBP was 85.97 in normal 
renal function group, 91.43 in unrecognized renal insufficiency group and 90.97 
in recognized renal insufficiency group. 
Discussion  
When the hemodynamic parameters distribution between three groups was 
analysed statistically using single factor ANOVA test, the mean difference of 
SBP values in unrecognized renal function group compared to normal renal 
function group was 4.17 (3% decrease) and between recognized renal 
insufficiency group compared to unrecognized renal insufficiency group was 
13.04 (8 % increase).  This was found to be statistically significant (p <0.05). 
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Similarly the mean difference of DBP values in unrecognized renal function 
group compared to normal renal function group was 5.46 (5% increase) and 
between recognized renal insufficiency group compared to unrecognized renal 
insufficiency group was 0.46 (1 % decrease).  This was found to be statistically 
significant (p <0.05). 
 
On calculating the effect size of SBP using Cohen’s “d” value (d = 0.38), a low 
practical significance was observed (65% of study subjects with SBP levels 
above 162 will have recognized renal insufficiency and 53% of study subjects 
with SBP between 149-162 will have unrecognized renal insufficiency) . 
 
Similarly on calculating the effect size of DBP using Cohen’s “d” value (d = 
0.41), a low practical significance was observed (65% of study subjects with 
DBP levels above 91 will have recognized and unrecognized renal 
insufficiency). 
Conclusion  
We can conclude that both systolic and diastolic blood pressure level is 
significantly higher in patients with recognized renal insufficiency compared 
with unrecognized renal insufficiency. 
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Blood Parameters 
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Blood Parameters Haemoglobin 
Random 
Blood Sugar 
Normal Renal Function 
Mean 11.98 146.95 
SD 1.76 97.97 
Unrecognized Renal 
Insufficiency 
Mean 10.86 139.00 
SD 1.46 80.38 
Recognized Renal 
Insufficiency 
Mean 12.03 186.90 
SD 2.27 98.17 
P value  
Single Factor ANOVA Test 
0.3171 0.1539 
 
Results 
While analyzing blood parameters in relation to renal function among stroke 
patients, the observed mean Hb level was 11.98 in normal renal function group, 
10.86 in unrecognized renal insufficiency group and 12.03 in recognized renal 
insufficiency group. Similarly the observed mean RBS was 146.95 in normal 
renal function group, 139.00 in unrecognized renal insufficiency group and 
196.90 in recognized renal insufficiency group.  
Discussion  
When the blood parameters distribution between three groups was analysed 
statistically using single factor ANOVA test,  the mean difference of Hb in 
unrecognized renal function group compared to normal renal function group was 
1.13 (10 % decrease) and between recognized renal insufficiency group 
compared to unrecognized renal insufficiency group was 1.18 (10 % increase).  
This was found to be statistically significant (p <0.05).  
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Similarly the mean difference of RBS values in unrecognized renal function 
group compared to normal renal function group was 7.95 (6% decrease) and 
between recognized renal insufficiency group compared to unrecognized renal 
insufficiency group was 47.90 (74% increase).  This was found to be statistically 
significant (p <0.05). 
 
It is evident that there is a statistically significant progressive decrease and 
increase in blood parameters across the three groups. On calculating the effect 
size of Hb using Cohen’s “d” value (d = 0.03), a very low practical significance 
was observed (54% of study subjects with Hb levels over 12.03 will have 
recognized and unrecognized renal insufficiency). 
 
Similarly on calculating the effect size of RBS using Cohen’s “d” value (d = 
0.43), a low practical significance was observed (65% of study subjects with 
RBS levels above 186 will have recognized renal insufficiency). 
 
Conclusion  
We can conclude that Haemoglobin and RBS levels were significantly higher in 
patients with recognized renal insufficiency compared with unrecognized renal 
insufficiency. 
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Modified Rankin Scale 
 
 
The 
Modified 
Rankin 
Scale 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal 
Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
MRS 1 6 9.68 1 14.29 0 0.00 
MRS 2 13 20.97 0 0.00 2 6.45 
MRS 3 19 30.65 0 0.00 3 9.68 
MRS 4 10 16.13 1 14.29 7 22.58 
MRS 5 8 12.90 3 57.14 11 35.48 
MRS 6 6 9.67 2 28.57 9 29.0 
Total 62 100.00 7 100.00 31 100.00 
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The Modified Rankin 
Scale Distribution 
Normal Renal 
Function 
Unrecognized Renal 
Insufficiency 
Recognized Renal 
Insufficiency 
Mean 3.32 4.43 4.65 
SD 1.47 1.62 1.17 
P value  
Single Factor ANOVA Test 
0.0001 
 
Results 
While analyzing MRS distribution in relation to renal function among stroke 
patients, it was observed that majority of the study subjects in normal renal 
function group were distributed in MRS 3 group (n=19, 30.65%), MRS 5 group 
in unrecognized renal insufficiency group (n=4, 57.14%) and MRS 5 group in 
recognized renal insufficiency group (n=11, 35.48%). 
Discussion  
When the MRS distribution between three groups was analysed statistically 
using single factor ANOVA test,  the mean difference of MRS in unrecognized 
renal function group compared to normal renal function group was 1.11 (25 % 
increase) and between recognized renal insufficiency group compared to 
unrecognized renal insufficiency group was 0.22 (5 % increase).  This was 
found to be statistically significant (p <0.05). Similarly on calculating the effect 
size of MRS using Cohen’s “d” value (d = 1.00), a high practical significance 
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was observed (84% of study subjects with MRS above 5 will have recognized 
and unrecognized renal insufficiency). 
Conclusion  
We can conclude that MRS was significantly higher in patients with recognized 
renal insufficiency compared to unrecognized renal insufficiency patients.  
 
Mortality Rate 
 
 
 
 
 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal Insufficiency 
% 
Recognized Renal 
Insufficiency 
% 
Survived  56 90.32 5 71.42 22 70.96 
Deaths 6 9.67 2 28.57 9 29.03 
Total  62 100 7 100 31 100 
     0.04053  
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Severity disability rate 
 
 
 
Normal 
Renal 
Function 
% 
Unrecognized 
Renal Insufficiency 
% 
Recognized 
Renal 
Insufficiency 
% 
MRS ≤ 3 38 67.85 1 20 5 22.72 
MRS > 3 18 32.14 4 80 17 72.27 
Total  56 100 5 100 22 100 
     0.0001  
 
Discussion  
Of the 100 patients with stroke included in the study, 62% had normal renal 
function, 31% had recognized renal insufﬁciency, and 7% had unrecognized 
renal insufﬁciency. Mortality rates are higher in patients with recognized and 
unrecognized renal insufﬁciency compared with patients with normal renal 
function (29%, %, and 28.5% and 9.6%) respectively, P < 0.05). Similarly, 
severe disability rates at discharge are also higher in patients with recognized 
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and unrecognized renal insufﬁciency compared with patients with normal renal 
function (72.27%, 80 %, and 32.14%) respectively, P < 0.05. 
 
Data Analysis 
 
 Descriptive statistics were done for all data and were reported in terms of 
mean values and percentages. Suitable statistical tests of comparison were 
done. Continuous variables were analyzed with the unpaired t test and 
ANOVA.. Categorical variables were analyzed with the Chi-Square Test and 
Fisher Exact Test. Statistical significance was taken as P < 0.05. The data 
was analysed using SPSS version 16 and Microsoft Excel 2007. 
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CONCLUSION 
 
1. Unrecognized renal insufﬁciency is found to be a common comorbidity 
among patients with acute stroke in our study. 
2. Unrecognized renal insufficiency is significantly common among older age 
group and more frequently in females compared to male in our study group.  
 
3. Mortality rate and severe disability rate are higher in patients with recognized 
and unrecognized renal insufﬁciency compared to patients with normal renal 
function.  
 
4. Our study did not show any significant difference in all outcomes between 
recognized and unrecognized renal insufﬁciency. 
 
Limitations of the Study  
1. Evaluation of renal function was based on a single serum creatinine 
measurement taken on admission. Single admission creatinine levels may not 
reﬂect their baseline renal function.  
2. Less number of patient are included in study. 
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3. The current study demonstrated only unrecognized renal insufﬁciency in 
acute stroke is associated with adverse short-term outcomes. However, long 
term outcome of stroke patients with renal dysfunction were not measured. 
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PROFORMA 
 
  
NAME :     AGE:     SEX: 
 
 
 
ADDRESS:     CONTACT NO: 
 
 
 
 
 
COMPLAINTS: 
 
 
 
HISTORY 
 
       ALCOHOLISM            YES           NO   DURATION:  
 
  
       HEAD INJURY             YES             NO 
 
 
       HYPOTHYROIDISM    YES             NO 
 
 
      KIDNEY DISEASE          YES           NO 
 
 
      SMOKER                           YES           NO 
        
 
      
    H/O   MEDICATION   - 
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RELEVANT CLINICAL EXAMINATION: 
 
 
GENERAL EXAMINATION  
 
 
 
 
SYSTEMIC EXAMINATION: 
 
 
CARDIOVASCULAR: 
 
 
 
RESPIRATORY: 
 
 
ABDOMEN : 
 
 
 
CNS: 
 
 
LABORATORY INVESTIGATIONS 
 
HB:    TC:    PLATELET: 
 
 
 
RBS          RFT: 
 
 
Lipid Profile 
 
Urine Routine 
 
 
 
CT/MRI Brain:                                                             
 
COMMENT: 
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CONSENT FORM 
 
GOVT. STANLEY MEDICAL COLLEGE, CHENNAI – 600001 
INFORMED CONSENT 
 
Study of Clinical Significance of Unrecognized Renal Dysfunction in Patients with Acute 
Stroke 
 
Place of study:  Government Stanley Medical College, Chennai 
 
 
I ……………………………………………. have been informed about the details of the study 
in my own language. 
I have completely understood the details of the study. 
I am aware of the possible risks and benefits, while taking part in the study. 
I agree to collect samples of blood/saliva/urine/tissue if study needs. 
I understand that I can withdraw from the study at any point of time and even then, I can 
receive the medical treatment as usual. 
I understand that I will not get any money for taking part in the study. 
I will not object if the results of this study are getting published in any medical journal, 
provided my personal identity is not revealed. 
I know what I am supposed to do by taking part in this study and I assure that I would extend 
my full cooperation for this study.   
  
 
Volunteer:       Witness: 
Name and address        Name and address  
Signature/thumb impression:     Signature/thumb impression 
Date:        Date: 
  
        
 Investigator Signature and date 
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GOVT. STANLEY MEDICAL COLLEGE, CHENNAI – 600001 
 
INFORMED CONSENT 
 
Study of Clinical Significance of Unrecognized Renal Dysfunction in 
Patients with Acute Stroke 
 
     AT GOVERNMENT STANLEY HOSPITAL, CHENNAI. 
 
நான் இந்த ஆராய்ச்சியில் விவரங்களை முற்றிலும் புாிந்து ககாண்டேன். 
ஆய்வில் பங்கு எடுத்து டபாது, சாத்தியமான அபாயங்கள் மற்றும் பயன்களை பற்றி 
நான் அறிந்துள்டைன். 
நான் எந்தகவாரு டவளையிலும் ஆய்வில் இருந்து திரும்ப முடியும், அதன் பின்னர், 
நான் வழக்கம் டபால் மருத்துவ சிகிச்ளச கபற முடியும் என்று புாிந்துககாள்கிடறன் 
நான் ஆய்வில் பங்கு எடுத்து பணம் எளதயும் கபற முடியாது என்று அறிந்துள்டைன். 
இந்த ஆய்வின் முடிவுகள் எந்த கமடிக்கல் ஜர்னலில் கவைியிேப்பே இருந்தால் நான் 
எதிர்க்கவில்ளை, என் தனிப்பட்ே அளேயாைத்ளத கவைிப்படுத்தப்பட்டு இருக்க 
கூோது. 
நான் இந்த ஆய்வில் பங்ககடுப்பதன் மூைம் நான் என்ன கசய்ய டபாகிடறன் என்று 
கதாியும் 
நான் இந்த ஆய்வில் என் முழு ஒத்துளழப்ளபயும் ககாடுப்டபன் என்று 
உறுதியைிக்கிடறன். 
 
தன்னார்வைர்           சாட்சி  
கபயர் மற்றும் முகவாி       கபயர் மற்றும் முகவாி 
ளககயாப்பம் / விரல் டரளக:      ளககயாப்பம் / விரல் 
டரளக: 
 
ஆராய்ச்சியாைராக        ளககயாப்பம் மற்றும் 
டததி  
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APPENDIX 
S.No Age Sex Infarct Hemo SHT DM CAD Smoker Alcoholic Cr MDRD CKD- MRS SBP DBP Hb RBS Dys- 
    
rrhage 
       
EPI 
     
lipidemia 
1 56 M yes - yes - - yes - 1.4 55.7 55.8 3 190 100 11 96 yes 
2 40 M yes - - yes - yes yes 1.4 59.7 62.4 5 140 90 12 136 yes 
3 36 M - yes yes - - yes yes 1.4 60.95 64.2 5 200 100 16 130 yes 
4 49 M yes - - - - - yes 1.2 68.4 70.6 2 160 80 14 89 
 5 55 M yes - - - - yes yes 0.7 124.4 106.2 3 130 80 14 61 yes 
6 43 M - yes yes yes - - yes 1.5 54 56.2 5 180 90 12 193 
 7 48 M yes - - - - yes yes 1.2 69 71 2 120 80 13 74 
 8 40 M - yes - - - yes yes 0.9 99 106.5 6 220 110 14 95 
 9 75 M yes - - - - - - 1 77 73.3 1 150 80 9 109 
 10 55 M - yes - - - yes yes 0.9 93 95.8 3 160 100 10 101 yes 
11 64 F - yes yes - - - - 1.2 48 47.7 6 180 110 12 114 yes 
12 62 M - yes yes yes - yes yes 1.6 46 45.5 5 190 100 16 264 yes 
13 58 F yes - yes - - - - 1.2 49 49.8 6 140 90 10 156 yes 
14 50 M yes - yes - - yes yes 1 84 87.4 2 130 70 11 124 
 15 40 M yes - yes - - - - 0.8 114 111.7 1 140 80 13 166 
 16 63 M yes - yes yes - 
 
yes 1.2 65 64 3 160 90 12 68 
 17 64 M yes - yes - - - - 0.6 144 106.3 3 150 80 9 108 
 18 60 M yes - yes - - yes yes 0.8 105 97 3 160 90 8 96 yes 
19 58 M yes - - yes - yes yes 1.5 51 50.6 2 160 80 14 308 yes 
20 45 M yes - yes - - - yes 0.8 111 107 3 140 80 11 82 
 21 65 M yes - yes - - - yes 0.9 90 89 4 160 100 12 118 
 22 45 M yes - yes - - - yes 0.9 97 103 2 130 90 14 85 
 23 70 M yes - - - - - - 1.2 63 61 5 150 80 10 112 
 24 68 M - yes yes - - - yes 1.6 46 44 4 190 110 11 95 yes 
25 65 M yes - yes - - yes yes 0.8 103 93 4 150 80 13 100 yes 
26 58 F yes - yes yes - - - 1.7 33 33 6 160 90 9 264 yes 
27 64 F yes - - - - - - 0.9 67 68 4 150 90 11 142 
 28 55 M - yes yes - - - yes 1.4 56 56 6 180 120 13 123 yes 
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S.No Age Sex Infarct Hemo SHT DM CAD Smoker Alcoholic Cr MDRD CKD- MRS SBP DBP Hb RBS Dys- 
    
rrhage 
       
EPI 
     
lipidemia 
29 64 M yes - - - - yes yes 1.2 65 64 3 140 80 10 84 yes 
30 68 M yes - - yes - - - 1.4 54 51 6 130 80 10 386 
 31 40 M - yes yes - - yes yes 1.2 71 75 5 140 100 15 280 
 32 52 M yes - - - - yes yes 0.9 94 98 1 160 80 12 90 yes 
33 60 M yes - yes yes - yes yes 1.3 60 59 3 140 70 12 186 yes 
34 61 M yes - SHT - - yes yes 0.8 105 96 3 130 80 10 104 yes 
35 50 F yes - _ - - yes yes 1.6 36 37 6 160 80 12 84 yes 
36 75 F yes - yes - - - - 0.7 86 85 5 140 70 9 366 yes 
37 64 F - yes _ - - _ - 0.6 107 96 5 170 120 11 140 yes 
38 72 F yes - yes yes - _ - 1.5 36 35 6 130 80 8 232 yes 
39 62 M - yes yes - - _ - 0.8 104 96 3 180 90 16 78 
 40 70 M yes - yes - - yes yes 0.8 102 91 5 140 80 11 160 
 41 45 M yes - yes yes yes yes yes 1.2 70 73 1 120 70 12 183 
 42 62 F yes - - - - _ - 0.9 91 91 3 160 90 13 106 
 43 56 M - yes yes yes - _ - 1.7 45 44 5 150 100 12 290 yes 
44 57 M yes - yes yes - yes yes 1 82 83 2 140 90 14 242 yes 
45 64 M - yes yes yes - yes yes 1.3 59 58 5 170 80 10 196 
 46 66 F yes - yes - - - - 1.7 32 31 5 160 70 10 90 
 47 54 F yes - yes yes - - - 0.8 79 84 1 180 90 11 214 yes 
48 69 M yes - yes yes - yes - 1.3 58 56 2 150 90 12 184 yes 
49 62 M - yes yes yes - yes yes 2.2 32 31 6 200 110 12 440 yes 
50 58 F yes - yes - - - - 1.2 49 50 1 130 80 12 88 
 51 52 M - yes yes - - yes yes 0.9 94 98 4 160 80 14 121 
 52 46 M - yes yes - - yes yes 1.2 69 72 3 220 100 13 86 
 53 72 M yes - - - - - - 1.2 63 60 3 170 90 10 77 
 54 58 M yes - yes yes - - - 0.8 106 99 4 130 70 12 344 
 55 64 M yes - yes - yes - - 0.8 103 94 3 120 80 9 95 
 56 54 F yes - yes - - - - 0.9 94 97 2 150 80 12 112 
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S.No Age Sex Infarct Hemo SHT DM CAD 
 
Smoker Alcoholic Cr MDRD CKD- MRS SBP DBP Hb RBS Dys- 
        rrhage               EPI           lipidemia 
57 50 M - yes yes - - yes yes 1.1 75 78 6 180 80 10 168 yes 
58 68 F yes - - yes - - - 1.2 48 47 4 130 90 12 304 yes 
59 56 M yes - yes   - yes - 1.4 56 56 3 140 90 11 102   
60 62 M yes - yes yes - 
alcohol, 
smoker - 0.8 104 96 2 120 80 12 192   
61 40 F yes - - - - yes yes 0.8 84 92 6 90 60 14 84   
62 58 M - yes yes yes yes yes yes 1.4 55 55 6 140 90 16 210 yes 
63 68 M yes - yes - - yes - 1.3 58 56 5 160 90 12 132   
64 72 F yes - - - - - - 1 58 56 5 160 90 9 80 yes 
65 54 F yes - - - - - - 0.7 93 98 1 130 80 11 144 yes 
66 48 M - yes yes - - yes yes 2.4 31 31 6 190 100 14 128 yes 
67 56 M yes - yes - - yes - 0.6 148 112 2 140 90 13 90   
68 61 M yes - - - - yes - 0.8 104 96 2 150 80 12 86   
69 57 M yes - yes yes - yes yes 0.7 124 105 3 130 80 14 284 yes 
70 48 M - yes yes - - yes yes 0.8 110 106 5 130 90 11 100 yes 
71 64 M yes - yes - yes yes yes 1.2 65 64 4 140 80 14 130 yes 
72 54 M yes - yes yes -   yes 0.8 107 101 2 120 70 12 242   
73 52 M yes - yes - - yes yes 0.9 94 98 2 180 80 12 94 yes 
74 69 M yes - yes - - - - 1.3 58 56 4 170 90 12 85   
75 46 M - yes yes - - yes yes 0.7 129 113 6 160 100 13 114   
76 74 M yes - - - - yes - 1.3 57 54 6 160 80 11 82 yes 
77 54 M - yes yes - - - yes 1.8 42 42 4 170 110 12 68   
78 55 M yes - - yes - - - 0.8 107 101 3 140 80 13 224 yes 
79 62 M yes - yes yes - - yes 1.5 50 49 4 100 70 14 277 yes 
80 90 F yes - yes - - - - 1 55 50 5 140 80 9 74   
81 60 F yes - yes - - - - 0.8 78 80 4 130 90 11 152   
82 48 F yes - - - - - - 0.9 71 76 3 100 70 12 83   
83 70 F yes - yes yes - - - 0.7 88 88 4 180 90 10 540 yes 
84 64 F yes - yes yes - - - 2.2 24 23 5 160 90 13 323 yes 
85 67 M - - yes - - - - 1.2 64 62 5 160 90 13 127 yes 
86 66 F yes - yes yes - - - 0.8 76 77 6 200 100 11 366 yes 
87 62 F yes - yes yes - - - 1.4 41 40 4 140 60 8 144  
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S.No Age Sex Infarct Hemo SHT DM CAD Smoker Alcoholic Cr MDRD CKD- MRS SBP DBP Hb RBS Dys- 
    rrhage        EPI      lipidemia 
88 58 F yes - yes yes - - - 0.8 78 81 4 200 110 9 480 yes 
90 65 M yes - - - - yes - 0.9 90 89 3 160 90 12 93 
 91 52 M yes - yes - - yes yes 0.8 108 102 2 180 80 15 103 
 92 50 M - yes yes - yes - yes 0.9 95 99 3 210 120 14 93 
 93 58 M yes - - yes - - - 1.8 41 41 4 160 90 14 293 yes 
94 60 M yes - yes - - yes yes 0.8 105 97 4 200 90 13 88 yes 
95 68 F yes - - - - - - 1.2 48 46 5 160 100 12 157 yes 
96 62 M yes - yes - - yes - 0.8 104 96 6 190 100 14 86 
 97 54 M yes - - - - yes - 0.8 107 101 3 130 80 13 112 yes 
98 70 F yes - yes yes yes - - 1.3 43 42 5 150 100 8 90 
 99 58 F yes - yes - yes - - 0.7 91 96 2 140 90 12 137 
 100 42 M - yes - - - - yes 1.5 56 57 5 190 120 16 163 
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ABBREVIATIONS 
ACE- Angiotensin converting enzyme  
ACTH - Adrenocorticotropic hormone 
ADH - Antidiuretic hormone 
AHA – American Heart Association 
AKI – Acute kidney injury 
ARF – Acute renal failure 
ATN – Acute tubular necrosis 
AV – Arterio venous 
BP – Blood pressure 
CAD – Coronary artery disease  
CKD – Chronic kidney disease 
Cr – Creatinine  
CKD – EPI - Chronic Kidney Disease Epidemiology Collaboration 
CVA – Cerebrovascular accident 
DM – Diabetes mellitus    
ECG – Electrocardiogram 
EGFR – Estimated glomerular filtration rate 
ERPF – Effective renal plasma flow 
HIV – Human immunodeficiency virus 
KIM – Kidney injury molecule 
MCA – Middle cerebral artery 
MDRD - Modification of Diet in Renal Disease 
MRS – Modified rankin scale  
NGAL - Neutrophil gelatinase-associated lipocalin 
RBF – Renal blood flow 
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RPF – Renal plasma flow 
SAH – Subarachnoid hemorrhage 
SHT – Systemic hypertension  
TIA – Transient ischemic attack 
UTI – Urinary tract infection 
 
